Evidence map›Paper›PMID 42148352›Full record

ArticleClinical case reports2026

Autoimmune Hepatitis Following COVID-19 Vaccination in a Patient With Ulcerative Colitis: A Case Report.

Marwah Algodi, Mohamed Nasser Elshabrawi, Mohamed Abuelazm, Ibrahim Gowaily, Omar Saab, Hatem Eltaly, Constantine Fisher

Abstract read
In one paragraph

Article in Clinical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Marwah AlgodiJersey Shore University Medical Center Neptune Township New Jersey USA.
Mohamed Nasser ElshabrawiFaculty of Medicine Port Said University Port Said Egypt.
Mohamed AbuelazmFaculty of Medicine Tanta University Tanta Egypt.
Ibrahim GowailyDepartment of Medicine Creighton University School of Medicine Omaha Nebraska USA.
Omar SaabNew York Presbyterian Queens Hospital Flushing New York USA.
Hatem EltalyCleveland Clinic Main Campus Cleveland Ohio USA.
Constantine FisherNew York Presbyterian Queens Hospital Flushing New York USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autoimmune hepatitis (AIH) following COVID-19 vaccination is a rare adverse event. We present the case of a 55-year-old male with a history of ulcerative colitis (UC) who developed AIH 3 weeks after receiving his second dose of the Pfizer-BioNTech mRNA vaccine. He presented with jaundice and significantly elevated liver enzymes. A liver biopsy confirmed the diagnosis of AIH. The patient was successfully treated with corticosteroids and azathioprine, leading to complete clinical and biochemical remission. This case highlights the potential for vaccine-induced autoimmune phenomena, particularly in individuals with preexisting autoimmune conditions, and underscores the importance of prompt diagnosis and treatment.

Indexed as

gastroenterologyhepatologyinfectioninflammatory bowel diseaseliver

Identifiers

PMID42148352
PMCPMC13173295

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.